These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 33849417)
1. Psychological Continuum of Elderly Patients Suffering from Arterial Hypertension with Metabolic Syndrome, Against the Background of Chronotherapy with a Fixed Combination of Amlodipine, Lisinopril and Rosuvastatin. Agarkov NM; Okhotnikov OI; Korneeva SI; Moskaleva EO; Moskalev AA; Kolomiets VI; Markelova AM; Markelova EA Kardiologiia; 2021 Mar; 61(3):36-41. PubMed ID: 33849417 [TBL] [Abstract][Full Text] [Related]
2. [The effect of antihypertensive chronotherapy on indicators of the daily blood pressure profile in elderly patients with arterial hypertension with a history of myocardial infarction.]. Agarkov NM; Proschayev KI; Lutay YA; Ilnitskiy AN; Korneeva SI; Markelova AM; Kolomiets VI Adv Gerontol; 2020; 33(5):972-976. PubMed ID: 33550755 [TBL] [Abstract][Full Text] [Related]
3. [Lisinopril, Amlodipine, Rosuvastatin as a Novel Fixed Combination in the Fight Against Cardiovascular Disease]. Semenova AE; Sergienko IV Kardiologiia; 2017 Oct; 57(10):73-79. PubMed ID: 29276932 [TBL] [Abstract][Full Text] [Related]
4. [A fixed-dose lisinopril+amlodipine+rosuvastatin combination: prospects for its use in patients with hypertension and concomitant dyslipidemia]. Podzolkov VI; Bragina AE; Osadchiy KK Ter Arkh; 2017; 89(12):133-140. PubMed ID: 29411773 [TBL] [Abstract][Full Text] [Related]
5. [A fixed-dose lisinopril and amlodipine combination in conjunction with rosuvastatin in patients with hypertensive disease and coronary heart disease]. Galeeva ZM; Galiavich AS Ter Arkh; 2014; 86(9):71-6. PubMed ID: 25518509 [TBL] [Abstract][Full Text] [Related]
6. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U; Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186 [TBL] [Abstract][Full Text] [Related]
7. [Ramipril plus amlodipine and lisinopril plus amlodipine fixed dose combinations and patient's adherence]. Simonyi G; Ferenci T Orv Hetil; 2016 Jan; 157(1):30-4. PubMed ID: 26708684 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial. Hong SJ; Jeong HS; Cho JM; Chang K; Pyun WB; Ahn Y; Hyon MS; Kang WC; Lee JH; Kim HS Clin Ther; 2019 Feb; 41(2):233-248.e9. PubMed ID: 30665829 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine. Asmar R; Gosse P; Queré S; Achouba A Blood Press Monit; 2011 Apr; 16(2):80-6. PubMed ID: 21372694 [TBL] [Abstract][Full Text] [Related]
10. Effects of amlodipine and lisinopril on left ventricular mass and diastolic function in previously untreated patients with mild to moderate diastolic hypertension. Beltman FW; Heesen WF; Smit AJ; May JF; de Graeff PA; Havinga TK; Schuurman FH; van der Veur E; Lie KI; Meyboom-de Jong B Blood Press; 1998 May; 7(2):109-17. PubMed ID: 9657538 [TBL] [Abstract][Full Text] [Related]
11. [Modern Fixed Combinations in the Correction of Arterial Hypertension and Dyslipidemia]. Galeeva ZM; Galyavich AS; Baleeva LV; Sabirzyanova AA; Kuznetsov MV Kardiologiia; 2024 May; 64(5):26-32. PubMed ID: 38841786 [TBL] [Abstract][Full Text] [Related]
12. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [TBL] [Abstract][Full Text] [Related]
13. [Therapeutic approaches to the Rational Use of trip-le combination therapy with a fixed combination of amlodipine, indapamide and perindopril arginine (TRIPLE COMBINATION) in patients with hypertension who do not control blood pressure on conventional treatment. (Description and main results of the TRIO program)]. Mareev VY; Minina YV; Begrambekova YL; Levin AM Kardiologiia; 2020 Jun; 60(5):1149. PubMed ID: 32515706 [TBL] [Abstract][Full Text] [Related]
14. EFFECTIVENESS OF LISINOPRIL AND AMLODIPINE COMBINATION AT HYPERTENSION WITH COMORBIDITY OF ARTERIOSCLEROSIS OBLITERANS IN GENERAL PRACTICE. Babinets LS; Levchuk RD; Halabitska IM; Kryskiv OI Wiad Lek; 2022; 75(10):2407-2411. PubMed ID: 36472269 [TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness of combined antihypertensive and cholesterol-lowering therapy in high-/very high-risk patients. Kónyi A; Sárszegi Z; Hild G; Gaszner B J Comp Eff Res; 2016 Jul; 5(4):355-64. PubMed ID: 27295112 [TBL] [Abstract][Full Text] [Related]
16. [Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy]. Statsenko ME; Derevianchenko MV Ter Arkh; 2014; 86(8):90-3. PubMed ID: 25306751 [TBL] [Abstract][Full Text] [Related]
17. [Hronotherapy Aspects of Efficiency Azilsartan Medoxomil in Combination Therapy in Patients With Hypertension and Metabolic Syndrome]. Skibitskiy VV; Fendrikova AV; Sirotenko DV; Skibitskiy AV Kardiologiia; 2016 Oct; 56(10):35-40. PubMed ID: 28290893 [TBL] [Abstract][Full Text] [Related]
18. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy of combined antihypertensive treatment with amlodipine and lisinopril in metabolic syndrome]. Shevchenko OP; Praskurnichiĭ EA; Savel'eva SA Ter Arkh; 2008; 80(4):54-9. PubMed ID: 18491582 [TBL] [Abstract][Full Text] [Related]
20. [The effect of changing of conventional antihypertensive therapy to a triple fixed combination therapy with rosuvastatin in high cardiovascular risk patients]. Ageev FT; Blankova ZN; Samsonova NS Kardiologiia; 2018 SMar; (S3):46-54. PubMed ID: 29782289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]